Patents
Nature Biotechnology 26, 55 - 56 (2008)
doi:10.1038/nbt0108-55
Reach-through claims for drug target patents: Rx for pharmaceutical policy
Robert A Bohrer1
Abstract
Recognizing the value of the discovery and validation of new pharmaceutical targets would be a major step forward for pharmaceutical policy.
- Robert A. Bohrer is at California Western School of Law, 225 Cedar Street, San Diego, California 92101, USA. e-mail: rab@cwsl.edu


